OR WAIT null SECS
© 2023 MJH Life Sciences and Consultant Live. All rights reserved.
September 28, 2023
Andrew Wang, MD; James Januzzi, MD; Michelle M. Kittleson, MD, PhD; and Milind Desai, MD, MBA, share a look into the future of oHCM treatment.
Michelle M. Kittleson, MD, PhD, comments on remaining unanswered questions regarding CMIs in treatment of oHCM, highlighting disease modification.
Expert cardiologists share approaches to implementing mavacamten and aficamten in the clinical treatment of oHCM.
September 21, 2023
Andrew Wang, MD, and Anjali Owens, MD, review the clinical trials of aficamten, a CMI used for treating patients with oHCM.